The purpose of this Standard and its information collection requirements is to provide protection for workers from adverse health effects associated with occupational exposure to Methylenedianiline (MDA) in General Industry. Employers must monitor worker exposures within the permissible exposure limits, provide workers with medical examinations and training, and establish and maintain worker exposure-monitoring and medical records.
US Code:
29 USC 651
Name of Law: The Occupational Safety and Health Act
US Code:
29 USC 657
Name of Law: The Occupational Safety and Health Act
US Code:
29 USC 655
Name of Law: The Occupational Safety and Health Act
The Agency is requesting an adjustment increase of 73 burden hours from 297 to 370 hours. The adjustment is the result of increasing the job hire rate from 10% to 25.6%, resulting in an increased number of workers: receiving initial medical examinations, being trained, receiving exposure monitoring training, and requesting access to records. Also, this adjustment occurred because of the increase in the methods of compliance hours section.
There is an overall adjustment increase in capital costs $6,566 (from $21,416 to $27, 982) resulting from an increase in the number of workers receiving medical examinations and, the cost of a medical examinations increasing from $168 to $187. In addition, the total cost of exposure monitoring increased as a result of more workers being covered by the exposure monitoring provisions and an increase in the cost of laboratory analysis from $107 to $119.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
MDA GI Standard.docx
OSH Act Section 8 USC 657.pdf
4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)